Selection and education of patients for inhaled insulin.
Inhaled insulin is a recent advance in insulin delivery that promises to be an effective alternative to subcutaneous insulin. Several insulin delivery systems are currently in development and the first of these has been approved for clinical use. Inhaled insulin offers greater flexibility and convenience for patients with diabetes and may be particularly useful in those who are reluctant to initiate or intensify insulin treatment. Although promising, potential concerns remain regarding its long-term effects on lungs. Also, excluding certain groups of patients such as smokers and those with respiratory illnesses will restrict its use at present. Lack of familiarity with the technology, especially relating to dose adjustments and inhaler device, is also likely to present fresh challenges. But, careful selection of patients, education, and continued support from health professionals is vital to ensure success with this new technology.
Bellary
Srikanth
S
Undergraduate Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham, UK.
Barnett
Anthony H
AH
D000280:Administration, Inhalation; D000284:Administration, Oral; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010353:Patient Education as Topic; D018579:Patient Selection; D012129:Respiratory Function Tests; D012907:Smoking
D007004:Hypoglycemic Agents; D007328:Insulin